TickerFacts.

RetinalGenix Technologies Inc. (RTGN): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$558.4K
Year ended 2025-12-31
-$477.9K
Trailing 12 months to 2026-06-30
2020-12-31: -$1.42M2021-12-31: -$1.17M2022-12-31: -$199.3K2023-12-31: -$451.7K2024-12-31: -$741.9K2025-12-31: -$558.4K-$558.4K
2020-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$558.4Kn/m2026-04-15, From 2025-01-01
2024-12-31-$741.9Kn/m2026-04-15, From 2024-01-01
2023-12-31-$451.7Kn/c2025-03-31, From 2023-01-01
2022-12-31-$199.3Kn/m2024-04-01, From 2022-01-01
2021-12-31-$1.17Mn/m2023-06-15, From 2021-01-01
2020-12-31-$1.42Mn/a2022-04-15, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
RetinalGenix Technologies Inc. (RTGN)2025-12-31-$558.4Kn/m
ALR Technologies SG Ltd. (ALRTF)2025-12-31-$1.87Mn/m
Odyssey Health, Inc. (ODYY)2025-07-31-$347.4Kn/m
Nu-Med Plus, Inc. (NUMD)2025-12-31-$48.0Kn/m
Stimcell Energetics Inc. (STME)2026-05-31-$312.1Kn/m
Global Innovative Platforms Inc. (GIPL)2025-09-30-$560.7Kn/m
Sigyn Therapeutics, Inc. (SIGY)2024-12-31-$872.4Kn/m
Vycor Medical Inc (VYCO)2025-12-31-$13.5Kn/m
Mountain Crest Acquisition Corp. V (MCAG)2025-12-31-$742.0Kn/m

Compare RTGN, ALRTF, ODYY, NUMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗